Talk:Jeffrey Bluestone

Jeff Bluestone Title EditTheodorajulienne (talk) 17:36, 16 August 2022 (UTC)
"Jeffrey Bluestone is the A.W. and Mary Margaret Clausen Distinguished Professor of Metabolism and Endocrinology and the director of the Hormone Research Institute in the Diabetes Center at the University of California, San Francisco" should be "Jeffrey Bluestone is the Chief Executive Officer and President of Sonoma Biotherapeutics, an immune tolerance company developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system.

Please add "He was the A.W. and Mary Margaret Clausen Distinguished Professor of Metabolism and Endocrinology and the director of the Hormone Research Institute in the Diabetes Center at the University of California, San Francisco, and was, for a number of years, an earlier executive vice chancellor and provost of that university."

Please remove "As of April 2016, he was also serving as the president and CEO of the Parker Institute for Cancer Immunotherapy." — Preceding unsigned comment added by Theodorajulienne (talk • contribs) 23:30, 21 August 2022 (UTC)

Please see here for sources to support these claims: https://www.biopharmadive.com/news/treg-cell-therapy-biotech-startups/629634/ https://www.bizjournals.com/sanfrancisco/news/2020/02/06/jeff-bluestone-sean-parker-sonoma-biotherapeutics.html https://www.statnews.com/2020/02/06/jeffrey-bluestone-sonoma/ https://endpts.com/jeffrey-bluestone-exits-parker-and-switches-focus-back-to-autoimmune-diseases-in-cell-therapy-2-0-launch/ https://www.sonomabio.com/team/jeff-bluestone-2 Theodorajulienne (talk) 17:36, 16 August 2022 (UTC)
 * Yellow check.svg Partly done: I added that he's CEO of SB without the advertorial flair. Did not remove either the professorship, nor the Parker Institute historical reference (his university bio still lists him as Professor), and there is no reason why his stint at Parker should be deleted. PK650 (talk) 03:28, 31 August 2022 (UTC)